Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 16729-444

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 16729-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (150 mg Tablet Container)

Label for BUPROPION HCl Extended-Release Tablets USP (XL) 150 mg by Accord Healthcare Inc. The label indicates a once-daily oral tablet, with a package count of 30 tablets. Storage instructions and warnings about not using with ZYBAN or similar medicines are included, along with manufacturer details.*

FDA Label Image

Principal Display Panel (300 mg Tablet Container)

Label for Bupropion Hydrochloride extended-release tablets, USP (XL) 300 mg by Accord Healthcare Inc. The label indicates once-daily oral dosage in a package of 30 tablets. It includes warnings against use with ZYBAN and instructs pharmacists to provide a Medication Guide. Manufacturing details for Accord Healthcare and Intas Pharmaceuticals Limited are also shown.*

FDA Label Image

Wellbutrin Chemical Structure (Bupropion Structure)

Chemical structure of Bupropion Hydrochloride, showing its molecular formula with Cl, N, H, and C elements indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.